Cancer Rates Rising Among People Under 50 Years Old
A 2022 study published in the journal Nature Reviews Clinical Oncology shows that incidence of cancers in adults under 50 years old has been increasing in the United States and many parts of the world since the 1990s.1 According to the National Cancer Institute (NCI), the rate of early-onset cancer cases in the U.S. grew […]
Some Children Suffered Seizures Following mRNA COVID Shots
A 2023 analysis published by researchers from Kaiser Permanente and the U.S. Centers for Disease Control and Prevention (CDC) in the journal Pediatrics compared vaccine adverse outcomes following administration of Pfizer/BioNTech’s Comirnaty messenger RNA (mRNA) COVID-19 shot and Moderna/NIAID’s Spikevax mRNA COVID-19 shot among recipients under five years old for a period of 1-21 days […]
Many COVID Patients Died from Ventilator-Associated Bacterial Infection
A 2023 study published in The Journal of Clinical Investigation found that secondary bacterial pneumonia that does not resolve was the cause of death in patients with COVID-19. The study showed that secondary bacterial pneumonia was very common in patients with COVID, affecting almost half the patients who required support from mechanical ventilation.1 Benjamin Singer, […]
BioNTech Sued in Germany for Injuries from the Comirnaty COVID mRNA Shot
Pharmaceutical company BioNTech SE of Mainz, Germany is facing a lawsuit filed by a German health care worker who was injured by the company’s Comirnaty COVID-19 messenger RNA (mRNA) shot, which it developed in collaboration with Pfizer, Inc. of the United States. The plaintiff said she suffered pain in her upper body, extreme swelling, fatigue […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
Most Authors of Psychopharmacology Textbooks Have Financial Conflicts of Interest
A 2022 study published in Community Mental Health Journal examined nine commonly used psychopharmacology textbooks to identify financial conflicts of interest of their authors and editors. The findings showed that two-thirds of psychopharmacology textbooks authors or editors received personal financial payments from pharmaceutical companies. Unlike most medical journals that require authors to disclose their financial […]
